bpc-157 status fda A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! Exciting news for peptides coming
Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for BREAKING: FDA projected to move BPC 157 to Category 1 as panel of advisers weigh looser restrictions on popular peptides. 59% chance. An FDA Committee Just Voted in Favor of PeptidesDespite the Agency's Opposition FDA reviews BPC 157, TB 500 and other peptides favored by RFK Jr. AP News
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
